company background image
MGRX logo

Mangoceuticals NasdaqCM:MGRX Stock Report

Last Price


Market Cap







12 Apr, 2024


Company Financials

Mangoceuticals, Inc.

NasdaqCM:MGRX Stock Report

Market Cap: US$6.2m

MGRX Stock Overview

Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States.

MGRX fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health6/6

Mangoceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mangoceuticals
Historical stock prices
Current Share PriceUS$0.24
52 Week HighUS$3.18
52 Week LowUS$0.14
1 Month Change61.53%
3 Month Change-20.56%
1 Year Change-76.48%
3 Year Changen/a
5 Year Changen/a
Change since IPO-93.94%

Recent News & Updates

Recent updates

Shareholder Returns

MGRXUS Consumer RetailingUS Market

Return vs Industry: MGRX underperformed the US Consumer Retailing industry which returned 18.2% over the past year.

Return vs Market: MGRX underperformed the US Market which returned 24.2% over the past year.

Price Volatility

Is MGRX's price volatile compared to industry and market?
MGRX volatility
MGRX Average Weekly Movement18.5%
Consumer Retailing Industry Average Movement4.5%
Market Average Movement6.1%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: MGRX's share price has been volatile over the past 3 months.

Volatility Over Time: MGRX's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company


Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at

Mangoceuticals, Inc. Fundamentals Summary

How do Mangoceuticals's earnings and revenue compare to its market cap?
MGRX fundamental statistics
Market capUS$6.18m
Earnings (TTM)-US$9.21m
Revenue (TTM)US$731.49k


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MGRX income statement (TTM)
Cost of RevenueUS$299.99k
Gross ProfitUS$431.50k
Other ExpensesUS$9.64m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)-0.40
Gross Margin58.99%
Net Profit Margin-1,259.40%
Debt/Equity Ratio0%

How did MGRX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.